Shanghai, China

Baoxin Wang

This inventor holds 1 USPTO granted patent. Top assignee: Biomobie (Shanghai) Regenerative Medicine Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Baoxin Wang. Retrieved from https://idiyas.com/inventor/baoxin-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Baoxin Wang - Innovator in Cardio-Cerebrovascular Therapeutics

Introduction

Baoxin Wang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medical technology, particularly in the treatment of cardio-cerebrovascular diseases. His innovative approach focuses on non-drug therapeutic solutions that aim to improve patient outcomes.

Latest Patents

Wang holds a patent for a "Non-drug cardio-cerebrovascular disease therapeutic apparatus." This invention provides a unique method for generating a pulse electromagnetic field through a specific waveform diagram of a pulse current. The apparatus includes four characteristic bands that effectively treat cardio-cerebrovascular diseases, demonstrating significant therapeutic effects.

Career Highlights

Baoxin Wang is associated with Biomobie (Shanghai) Regenerative Medicine Co., Ltd., where he applies his expertise in regenerative medicine. His work is pivotal in advancing non-invasive treatment options for patients suffering from cardio-cerebrovascular conditions.

Collaborations

Wang collaborates with notable colleagues, including Jian Wang and Fan Bu, who contribute to the innovative projects at Biomobie. Their combined efforts enhance the research and development of effective therapeutic solutions.

Conclusion

Baoxin Wang's contributions to the field of cardio-cerebrovascular therapeutics highlight the importance of innovation in medical technology. His work continues to pave the way for non-drug treatment options that can significantly improve patient health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…